VLA1601 is a purified and inactivated vaccine specifically designed to protect against the Zika virus
The study demonstrated strong clinical outcomes, with 94.8 per cent of subjects remaining free from major target limb amputation at one year
Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
This is the first industry-academia collaboration in the country, initiated through the CSR route, for advancing research in the areas of immuno-therapeutics and regenerative medicines
With over two decades of extensive experience, Lal has established himself as a transformational leader in the FMCG and consumer goods sectors
Allergan Aesthetics reaffirms commitment to empowering girls through STEM mentorship and education initiatives
In the next five years, an additional 75,000 seats are expected to be added across both undergraduate and postgraduate levels
Revenues up 13.1% year-over-year; Continued momentum driven by organic growth, strategic partnerships, and acquisitions
OS is a key secondary endpoint of the 948-patient study, which is evaluating whether adding AstraZeneca's PD-L1 inhibitor to standard FLOT chemotherapy
XTANDI is the first and only androgen receptor inhibitor-based regimen to demonstrate overall survival benefit in this patient population, supporting its earlier use in this setting
Subscribe To Our Newsletter & Stay Updated
